Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Estrigenix Therapeutics Inc
Profile last edited on: 5/12/2023      CAGE: 8ESQ4      UEI: T25FLAVQHKP5

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2019
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2370 N 103rd Street
Wauwatosa, WI 53226
   (414) 288-7374
   N/A
   N/A
Location: Single
Congr. District: 04
County: Milwaukee

Public Profile

Currently there is no description available for this company.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$299,056
Phase II Dollars
$0
Total Awarded
$299,056

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $299,056
Project Title: Development of EGX358, an ER-beta Agonist to Treat Hot Flashes & Menopause-Related Memory Loss

Key People / Management

  William Donaldson

Company News

There are no news available.